Analysts Offer Insights on Healthcare Companies: WellCare Health Plans (NYSE: WCG) and Bristol Myers (NYSE: BMY)

By Carrie Williams

Analysts have been eager to weigh in on the Healthcare sector with new ratings on WellCare Health Plans (NYSE: WCG) and Bristol Myers (NYSE: BMY).

WellCare Health Plans (NYSE: WCG)

Jefferies analyst David Windley reiterated a Hold rating on WellCare Health Plans (NYSE: WCG) yesterday and set a price target of $142. The company’s shares closed yesterday at $146.63.

According to TipRanks.com, Windley is a top 100 analyst with an average return of 15.5% and a 72.4% success rate. Windley covers the Healthcare sector, focusing on stocks such as Quintiles Transnational, PRA Health Sciences, and Charles River Labs.

WellCare Health Plans has an analyst consensus of Moderate Buy, with a price target consensus of $158.50.

Bristol Myers (NYSE: BMY)

Jefferies analyst Jeffrey Holford reiterated a Buy rating on Bristol Myers (NYSE: BMY) yesterday and set a price target of $64. The company’s shares closed yesterday at $52.93.

According to TipRanks.com, Holford is a 4-star analyst with an average return of 6.3% and a 67.5% success rate. Holford covers the Healthcare sector, focusing on stocks such as Parnell Pharmaceuticals, Johnson & Johnson, and Sanofi-Aventis Sa.

Bristol Myers has an analyst consensus of Moderate Buy, with a price target consensus of $58.50.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.